| Name | FBXL19 antisense RNA 1 (head to head) |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n FBXL19‐AS1 is a long non‑coding RNA that has been found to play a prominent oncogenic role in diverse human diseases. In several solid tumors—including colorectal, lung, breast, hepatocellular, nasopharyngeal, osteosarcoma and cervical cancers—FBXL19‑AS1 is frequently overexpressed and its high levels correlate with advanced stages, enhanced metastatic potential, and poor patient prognosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Mechanistically, FBXL19‑AS1 primarily functions as a competing endogenous RNA (ceRNA) that “sponges” various tumor‑suppressive microRNAs—including miR‑203, miR‑431‑5p, miR‑203a‑3p, miR‑876‑5p, miR‑346 and miR‑193a‑5p—thereby de‐repressing a range of downstream oncogenic targets such as RAF1, FOXM1, PBOV1, COL1A1, and others."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " In some contexts, FBXL19‑AS1 is further regulated by RNA‐binding proteins (e.g. LIN28A) or epigenetic modifiers (e.g. EZH2 and SUZ12), reinforcing its ability to promote cell cycle progression, inhibit apoptosis, and drive epithelial–mesenchymal transition (EMT) as well as angiogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role in tumor cells, FBXL19‑AS1 has also been implicated in modulating the tumor microenvironment and treatment response. For instance, in glioma, it participates in regulating blood–tumor barrier permeability through a mechanism involving STAU1‑mediated decay of ZNF765 mRNA"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", and its circulating levels in serum have been proposed as diagnostic and prognostic biomarkers in conditions such as hepatocellular carcinoma, acute pancreatitis, and pediatric acute myeloid leukemia."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "15"}]}, {"type": "t", "text": " Moreover, emerging evidence from studies in cholangiocarcinoma underscores its broader participation in complex ceRNA regulatory networks across malignancies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies highlight the multifaceted roles of FBXL19‑AS1 in cancer biology—from modulating key signaling pathways and cellular behaviors to serving as a potential biomarker and therapeutic target. Its ability to integrate diverse regulatory inputs and impact multiple oncogenic processes makes FBXL19‑AS1 an attractive candidate for further investigation in cancer diagnostics and treatment."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "13"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "14"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "18"}, {"type": "fg_f", "ref": "16"}, {"type": "fg_f", "ref": "15"}, {"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Bo Shen, Yuan Yuan, Yan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA FBXL19-AS1 plays oncogenic role in colorectal cancer by sponging miR-203."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2017.05.008"}], "href": "https://doi.org/10.1016/j.bbrc.2017.05.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28479250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28479250"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Qian Jiang, Li Cheng, Daiyuan Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FBXL19-AS1 exerts oncogenic function by sponging miR-431-5p to regulate RAF1 expression in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181804"}], "href": "https://doi.org/10.1042/BSR20181804"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30610161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30610161"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Liming Wang, Xin Zhang, Yang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29251"}], "href": "https://doi.org/10.1002/jcp.29251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31566718"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31566718"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Guolei Dong, Teng Pan, Dongdong Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gmz110"}], "href": "https://doi.org/10.1093/abbs/gmz110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31696201"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31696201"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "D-J Yu, Y-H Li, M Zhong "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201906_18065"}], "href": "https://doi.org/10.26355/eurrev_201906_18065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31210311"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31210311"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhenmin Ding, Pengcheng Ye, Xiaohu Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FBXL19-AS1 promotes breast cancer cells proliferation and invasion via acting as a molecular sponge to miR-718."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20182018"}], "href": "https://doi.org/10.1042/BSR20182018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30886065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30886065"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yudan Chen, Linglin Yang "}, {"type": "b", "children": [{"type": "t", "text": "FBXL19-AS1 aggravates the progression of hepatocellular cancer by downregulating KLF2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J BUON (2021)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34564989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34564989"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Xiaoyong Huang, Haiyan Shi, Xinghai Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Res (Thessalon) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40709-021-00151-8"}], "href": "https://doi.org/10.1186/s40709-021-00151-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34399848"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34399848"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hongjun Dong, Chao Huang, Jingjing Huang "}, {"type": "b", "children": [{"type": "t", "text": "FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2021.12286"}], "href": "https://doi.org/10.3892/mmr.2021.12286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34278444"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34278444"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Runsang Pan, Zhixu He, Wanyuan Ruan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Onco Targets Ther (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/OTT.S160963"}], "href": "https://doi.org/10.2147/OTT.S160963"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30555237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30555237"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yayuan Zhang, Xiaojun Xiao, Wenbing Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LIN28A-stabilized FBXL19-AS1 promotes breast cancer migration, invasion and EMT by regulating WDR66."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vitro Cell Dev Biol Anim (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11626-019-00361-4"}], "href": "https://doi.org/10.1007/s11626-019-00361-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31140103"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31140103"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xiaobai Liu, Peiqi Wu, Rui Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "RNA Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15476286.2020.1795583"}], "href": "https://doi.org/10.1080/15476286.2020.1795583"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32713259"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32713259"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Q Ma, G-F Gan, Y Niu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of associations of FBXL19-AS1 with occurrence, development and prognosis of acute pancreatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202012_24176"}], "href": "https://doi.org/10.26355/eurrev_202012_24176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33378025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33378025"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Dingdong He, Xiaokang Zhang, Xinyu Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identify and Validate the Transcriptomic, Functional Network, and Predictive Validity of FBXL19-AS1 in Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fonc.2020.609601"}], "href": "https://doi.org/10.3389/fonc.2020.609601"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33344260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33344260"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hongling Sheng, Jiajia Zhang, Yan Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gene Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jgm.3317"}], "href": "https://doi.org/10.1002/jgm.3317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33474753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33474753"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Li Guo, Yuyang Dou, Yifei Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Comput Struct Biotechnol J (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.csbj.2021.10.014"}], "href": "https://doi.org/10.1016/j.csbj.2021.10.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34745457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34745457"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Shengkang Dai, Desheng Yao "}, {"type": "b", "children": [{"type": "t", "text": "An immune-associated ten-long noncoding RNA signature for predicting overall survival in cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/tcr-21-2390"}], "href": "https://doi.org/10.21037/tcr-21-2390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35116378"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35116378"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jin Hao, Y U Jia, Wang Zi-Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Mechanism of flavonoids of Sophorae Fructus in inhibiting proliferation, migration and invasion of hepatocellular carcinoma cells by regulating LncRNA FBXL19-AS1/miR-342-3p pathway]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Zhong Yao Za Zhi (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.19540/j.cnki.cjcmm.20200302.401"}], "href": "https://doi.org/10.19540/j.cnki.cjcmm.20200302.401"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33164374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33164374"}]}]}]}
|
| Synonyms | NCRNA00095 |
| Proteins | FBAS1_HUMAN |
| NCBI Gene ID | 283932 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
FBXL19-AS1 has 2,495 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 24 datasets.
Click the + buttons to view associations for FBXL19-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of FBXL19-AS1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of FBXL19-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of FBXL19-AS1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of FBXL19-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of FBXL19-AS1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with FBXL19-AS1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of FBXL19-AS1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of FBXL19-AS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of FBXL19-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at FBXL19-AS1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of FBXL19-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of FBXL19-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of FBXL19-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of FBXL19-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of FBXL19-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of FBXL19-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of FBXL19-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of FBXL19-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of FBXL19-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of FBXL19-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of FBXL19-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of FBXL19-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at FBXL19-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of FBXL19-AS1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |